Literature DB >> 1633894

Elevated interleukin-6 levels in peritoneal fluid of patients with pelvic pathology.

R P Buyalos1, V A Funari, R Azziz, J M Watson, O Martinez-Maza.   

Abstract

OBJECTIVE: To determine if interleukin 6 (IL-6) is a normal constituent of peritoneal fluid (PF), and if various types of pelvic pathology influence its presence within the PF microenvironment. STUDY
DESIGN: Peritoneal fluid from 73 women obtained at the time of laparoscopy was examined for the presence of IL-6 using an IL-6 specific sandwich enzyme-linked immunosorbent assay. Thirty-nine patients had pelvic endometriosis, 17 had nonendometriotic pelvic adhesive disease, and 17 subjects undergoing tubal sterilization without evidence of pelvic pathology served as controls.
RESULTS: Immunoreactive IL-6 was observed in the PF of all 73 subjects (range 0.26 to 11.16 ng/mL). The mean concentration of IL-6 was higher in women with nonendometriotic pelvic adhesions as compared with control subjects (1.28 +/- 0.16 versus 0.80 +/- 0.06 ng/mL, P less than 0.03). There was no difference in the mean peritoneal concentrations of IL-6 between women with endometriosis (1.16 +/- 0.28 ng/mL) and controls, P = 0.38. Twenty-seven of 73 patients (37%) demonstrated elevated levels (greater than 1.0 ng/mL) of IL-6. Patients with pelvic adhesions were significantly more likely to have elevated concentrations of IL-6 than controls (10/17 [59%] versus 3/17 [18%], P less than 0.02). Alternatively, the percentage of patients with elevated IL-6 concentrations did not differ between patients with endometriosis or controls (14/39 [36%] versus 3/17 [18%], P greater than 0.10).
CONCLUSIONS: These findings demonstrate that IL-6 is a normal constituent of PF and that elevated levels are found in many patients with pelvic adhesions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1633894

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  10 in total

1.  Peptide inhibitors of MK2 show promise for inhibition of abdominal adhesions.

Authors:  Brian C Ward; Sandra Kavalukas; Jamie Brugnano; Adrian Barbul; Alyssa Panitch
Journal:  J Surg Res       Date:  2011-02-23       Impact factor: 2.192

Review 2.  Does dienogest influence the inflammatory response of endometriotic cells? A systematic review.

Authors:  Giovanni Grandi; Michael Mueller; Nick A Bersinger; Angelo Cagnacci; Annibale Volpe; Brett McKinnon
Journal:  Inflamm Res       Date:  2015-12-09       Impact factor: 4.575

3.  Aberrant activation of signal transducer and activator of transcription-3 (STAT3) signaling in endometriosis.

Authors:  Byung Gak Kim; Jung-Yoon Yoo; Tae Hoon Kim; Jung-Ho Shin; John F Langenheim; Susan D Ferguson; Asgerally T Fazleabas; Steven L Young; Bruce A Lessey; Jae-Wook Jeong
Journal:  Hum Reprod       Date:  2015-03-06       Impact factor: 6.918

Review 4.  Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications.

Authors:  Pamela Stratton; Karen J Berkley
Journal:  Hum Reprod Update       Date:  2010-11-23       Impact factor: 15.610

5.  Changes of cytokines levels in peritoneal fluids of patients with endometriosis and its effect on reproductive activity.

Authors:  Y Liu; L Luo; H Zhao
Journal:  J Tongji Med Univ       Date:  2000

6.  Endometrial BCL6 Overexpression in Eutopic Endometrium of Women With Endometriosis.

Authors:  Emily Evans-Hoeker; Bruce A Lessey; Jae Wook Jeong; Ricardo F Savaris; Wilder A Palomino; Lingwen Yuan; David P Schammel; Steven L Young
Journal:  Reprod Sci       Date:  2016-05-24       Impact factor: 3.060

7.  Associations among serum pro- and anti-inflammatory cytokines, metabolic mediators, body condition, and uterine disease in postpartum dairy cows.

Authors:  Ramanathan K Kasimanickam; Vanmathy R Kasimanickam; Jesse R Olsen; Erin J Jeffress; Dale A Moore; John P Kastelic
Journal:  Reprod Biol Endocrinol       Date:  2013-11-09       Impact factor: 5.211

8.  CRISPLD2 is a target of progesterone receptor and its expression is decreased in women with endometriosis.

Authors:  Jung-Yoon Yoo; Heesung Shin; Tae Hoon Kim; Won-Seok Choi; Susan D Ferguson; Asgerally T Fazleabas; Steven L Young; Bruce A Lessey; Un-Hwan Ha; Jae-Wook Jeong
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

9.  Omega-3 polyunsaturated Fatty acids suppress the cystic lesion formation of peritoneal endometriosis in transgenic mouse models.

Authors:  Kensuke Tomio; Kei Kawana; Ayumi Taguchi; Yosuke Isobe; Ryo Iwamoto; Aki Yamashita; Satoko Kojima; Mayuyo Mori; Takeshi Nagamatsu; Takahide Arimoto; Katsutoshi Oda; Yutaka Osuga; Yuji Taketani; Jing X Kang; Hiroyuki Arai; Makoto Arita; Shiro Kozuma; Tomoyuki Fujii
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

10.  Evaluation of BCL6 and SIRT1 as Non-Invasive Diagnostic Markers of Endometriosis.

Authors:  Alison M Sansone; Brooke V Hisrich; R Brandt Young; William F Abel; Zachary Bowens; Bailey B Blair; Avery T Funkhouser; David P Schammel; Lisa J Green; Bruce A Lessey; Anna V Blenda
Journal:  Curr Issues Mol Biol       Date:  2021-09-28       Impact factor: 2.976

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.